Ongoing and Published work

The European Network for Sinonasal Cancer Research (EUSICA) - A pan-European initiative targeting a group of orphan tumours

https://pubmed.ncbi.nlm.nih.gov/38447380/

Link to journal homepage

​

EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report

https://pubmed.ncbi.nlm.nih.gov/37573683/

Link to journal homepage

​

Sinonasal Cancer: Improving Classification, Stratification and Therapeutic Options

https://pubmed.ncbi.nlm.nih.gov/36980561/

Link to journal homepage

​

DNA methylation-based classification of sinonasal tumors

https://pubmed.ncbi.nlm.nih.gov/36443295/

Link to journal homepage

​

Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal Cancers

https://pubmed.ncbi.nlm.nih.gov/36431263/

Link to journal homepage

Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy

https://pubmed.ncbi.nlm.nih.gov/33402692/

Link to journal homepage

​

Clinical Outcomes, Kadish-INSICA Staging and Therapeutic Targeting of SSTR2 in Olfactory Neuroblastoma
https://pubmed.ncbi.nlm.nih.gov/34980502/

Link to journal homepage

​

International Multicenter Study of Clinical Outcomes of Sinonasal Melanoma Shows Survival Benefit for Patients Treated with Immune Checkpoint Inhibitors and Potential Improvements to the Current TNM Staging System
PubMed coming soon

Link to journal homepage

​

Precision medicine in rare tumors and the need for multicenter trials and international collaboratives: Sinonasal cancer as paradigm

https://pubmed.ncbi.nlm.nih.gov/32340860/

Link to journal homepage

​

Coordinator
Matt Lechner, MD PhD (m.lechner@ucl.ac.uk)